Last reviewed · How we verify

NCT04286178

Exercise, Creatine and Coenzyme Q10 for Childhood Myositis

Completed NA Last updated 22 March 2024
What this trial tests

NA trial testing creatine monohydrate in Myositis, Juvenile in 15 participants. Completed in 5 March 2024.

Timeline
6 April 2021
Primary endpoint
5 March 2024
5 March 2024

Quick facts

Lead sponsorThe Hospital for Sick Children
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposesupportive care
Enrollment15
Start date6 April 2021
Primary completion5 March 2024
Estimated completion5 March 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

The Hospital for Sick Children

Who can join

Adults 7 to 18, any sex, with Myositis, Juvenile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children with JDM are weak and get tired because their muscles aren't able to work like healthy muscles. This can make it hard for them to do normal everyday things and can make them less happy about their lives compared to children without the disease. There are two nutritional supplements that help muscles use energy and recover after exercise: creatine and coenzyme Q10. If the muscle has more energy, it may not be as weak and may not feel as tired or sore after exercise. Because of this we want to see if having children with JDM take creatine and coenzyme Q10 can make them stronger and less tired. If this works, we hope it will let them be able to do the things that healthy children can do, and make them feel better about their lives.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of creatine monohydrate

Trials testing the same drug.

Other The Hospital for Sick Children trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04286178.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing